Introduction
Glycosyltransferases (GTs) are a large family of enzymes that are encoded by about 1-2% of the coding regions of all genomes sequenced to date. These enzymes catalyze the biosynthesis of glycosidic linkages by the stereo-and regiospecific transfer of monosaccharides from donors, typically nucleotide sugars, to diverse acceptors such as saccharides, lipids, proteins, DNA and natural products (Taniguchi et al. 2002) . GTs biosynthesize highly abundant biopolymers such as cellulose (Mutwil et al. 2008) , amylose (Ball and Morell 2003) and chitin (Merzendorfer 2006) , as well as therapeutically important glycosylated natural product antibiotics (Walsh et al. 2003; Křen and Řezanka 2008) and anti-cancer agents (Griffith et al. 2005; Zhang et al. 2006) . They play important roles in a variety of normal biological processes (Ohtsubo and Marth 2006) and are implicated in many diseases and infections (Freeze and Aebi 2005; Vigerust and Shepherd 2007) . Therefore, they are attractive drug targets, and a detailed understanding of their mechanisms aids in the design of new therapeutic inhibitors (Hinou and Nishimura 2009) .
GTs are classified as either inverting or retaining, depending on whether the anomeric configuration of the transferred monosaccharide in the product is inverted or remains the same as that in the donor substrate. It is generally accepted that inverting GTs transfer monosaccharides from the donor to the acceptor, in a single-step S N 2-like reaction, aided by an enzymatic base catalyst (Breton et al. 2006; Lairson et al. 2008) . In contrast, the mechanism by which retaining GTs transfer monosaccharides with net retention of configuration has resisted elucidation, despite extensive experimental and computational studies. A double-displacement mechanism, in which the monosaccharide is first transferred to the enzyme forming a glycosyl-enzyme intermediate and subsequently transferred to the acceptor ( Figure 1A ), has been suggested by analogy to the well-characterized retaining glycosidases (Davies 2001; Breton et al. 2006; Lairson et al. 2008) . This mechanism is supported by the chemical rescue of an inactive α-(1 → 3)-galactosyltransferase mutant, in which the putative enzymatic nucleophile Glu 317 was replaced by Ala (Monegal and Planas 2006) . However, conclusive evidence for the formation of covalent glycosyl-enzyme intermediates has been elusive (Lairson et al. 2004 (Lairson et al. , 2008 Breton et al. 2006; Monegal and Planas 2006 ). An alternative mechanism, referred to as S N i, proceeds via a front-side single displacement forming an oxocarbenium ion-like transition state ( Figure 1B ) (Davies 2001; Persson et al. 2001; Gibson et al. 2002; Flint et al. 2005; Breton et al. 2006; Lairson et al. 2008 ). While such a mechanism can explain the retention of stereochemistry at the anomeric center without invoking a glycosyl-enzyme intermediate, the formation of this transition state would be sterically and entropically unfavorable. Recently, a new mechanism, referred to as S N i-like, involving the formation of a short-lived ion pair intermediate has been suggested (Lairson et al. 2008; Goedl and Nidetzky 2009) . The intermediate undergoes a small shift in its position in the enzyme-active site, allowing the acceptor to attack the donor on the same face that the nucleotide departs from ( Figure 1C) . ABO is the most important blood group system in transplantation and transfusion medicine. The A and B antigenic determinants are cell-surface oligosaccharides biosynthesized by the GTs, α-(1 → 3)-N-acetylgalactosaminyltransferase (GTA; EC 2.4.1.40) and α-(1 → 3)-galactosyltransferase (GTB; EC 2.4.1.37). GTA and GTB are highly homologous, differing in only 4 of 354 amino acids (Arg/Gly 176, Gly/Ser 235, Leu/Met 266 and Gly/Ala 268), but they possess distinct donor specificities (Yamamoto et al. 1990) . GTA catalyzes the transfer of N-acetylgalactosamine (GalNAc) from uridine
antigen, where R may be a protein or lipid) acceptor resulting in the A-trisaccharide antigen, and GTB catalyzes the transfer of galactose (Gal) from uridine 5′-diphosphogalactose (UDP-Gal, 2) to α-L-Fucp-(1 → 2)-β-D-Galp-OR resulting in the B-trisaccharide antigen (Supplementary data, Figure S1 ).
The structures, activities and binding properties of recombinant soluble forms of these enzymes have been studied extensively (Patenaude et al. 2002; Marcus et al. 2003; Angulo et al. 2006; Alfaro et al. 2008; Soya et al. 2009; Pesnot et al. 2010) . GTA and GTB are believed to undergo extensive structural rearrangement during a catalytic cycle (Alfaro et al. 2008; Pesnot et al. 2010) . Moreover, UDP has been suggested to have a role in deprotonation of the 3-OH of the acceptor activating it for nucleophilic attack (Lairson et al. 2008) . When conformational changes and/or substrate contacts are impaired, the catalytic turnover drops dramatically, although these reactions occur with retention of stereochemistry (Yazer and Palcic 2005; Letts et al. 2006; Alfaro et al. 2008 ). In the absence of an acceptor, GTA and GTB also catalyze the slow hydrolysis of donor, which can be considered as a transfer to water rather than to the acceptor, with retention of configuration (Sindhuwinata et al. 2010) . The slow rate of hydrolysis is attributed to the inability of the enzyme to form all contacts in the closed conformation.
Based on an analysis of X-ray crystal structures and the results of molecular modeling, Patenaude et al. (2002) proposed that, in both GTA and GTB, Glu 303 could serve as the catalytic nucleophile for a double-displacement mechanism. A 30,000-fold decrease in the enzymatic activity of GTB upon replacement of Glu 303 with Ala provides additional support for the proposal that this position plays a critical role in enzymatic activity (Patenaude et al. 2002) . Here, to test the hypothesis that residue Glu 303 serves as the catalytic nucleophile in both GTA and GTB, the enzymatic properties of single-point mutants, in which Glu 303 is replaced with Cys (i.e. GTA E303C and GTB E303C ), were investigated by using electrospray ionization mass spectrometry (ES-MS) measurements. Direct experimental evidence for the formation of a covalent glycosyl-enzyme intermediate by GTA E303C and GTB E303C is reported. Using tandem MS, the site of glycosylation was identified in both mutants. Evidence that exposure of the glycosyl-enzyme intermediates to a disaccharide acceptor results in the formation of the corresponding enzymatic trisaccharide products was also obtained. These findings suggest that GTA E303C and GTB E303C may operate by a doubledisplacement mechanism.
Results and discussion
As was found by ES-MS for wild-type GTA and GTB (i.e. GTA WT and GTB WT ) (Soya et al. 2009 ), the GTA E303C and GTB E303C mutants exist preferentially as homodimers in aqueous solution at neutral pH and 37°C (Supplementary data, Figure S2 ). Incubation of GTA WT or GTB WT in the presence of their respective donor substrates (1 or 2) and excess Mn 2+ , which serves as the metal ion cofactor, at 37°C and pH 7 for 30 min results in the enzyme-catalyzed hydrolysis of the donor giving uridine 5′-diphosphate (UDP, 3) and the corresponding monosaccharide (GalNAc or Gal) ( Figure 2A and Supplementary data, Figure S3A ) (Soya et al. 2009 ). For GTB WT , k cat for UDP-Gal donor hydrolysis at 25°C is 2 h −1 and the reaction occurs with retention of configuration of the released α-D-galactose (Sindhuwinata et al. 2010 ). In the case of GT E303C , ions corresponding to the free GT E303C homodimer and the GT E303C homodimer bound with donors (1 or 2 + Mn), or UDP, as (3 + Mn), were identified under the same conditions as above ( Figure 2B and Supplementary data, S3B). More importantly, however, ions with mass-to-charge ratios consistent with those expected for the GT E303C homodimers covalently bound to a monosaccharide (i.e. (GTA E303C ) 2 → GalNAc or (GTB E303C ) 2 → Gal, respectively) were detected (Supplementary data, Table S1 ). Similar results were obtained upon incubation of GTA E303C with 2 and GTB E303C with 1, although significantly longer incubation times ( 24 h) were required to produce detectable levels of the corresponding GTA E303C → Gal or GTB E303C → GalNAc (Supplementary data, Figure S4 ). Furthermore, when both GT E303C mutants were incubated in the presence of their respective donor, the acceptor (α-L-Fucp-(1 → 2)-β-D-Galp-O (CH 2 )CH 3 ) and excess Mn 2+ , ion signal for the glycosyl-enzyme intermediates was no longer detected by ES-MS ( Figure 2C and Supplementary data, S3C). Instead, ions corresponding to the enzymatic products, the A-and B-trisaccharides and 3, which binds as (3 + Mn) to the GT E303C dimers, were detected. The k cat -values for the formation of products for GTA E303C and GTB E303C are 0.9 and 1.3 s −1 , respectively, compared with 17 and 5 s −1 for the corresponding wild-type enzymes (Marcus et al. 2003) .
Using a higher concentration of Mn 2+ (10 mM), the GTA E303C dimer was shown to be fully converted to intermediate, (GTA E303C ) 2 → 2GalNAc, within 2 h, comparable to the rate of donor hydrolysis by GTB WT (Supplementary data, Figure S5A ). UDP is not present, and the conformation of this intermediate is unknown. Importantly, exposure of the purified intermediate to the acceptor resulted in the slow regeneration of the free enzyme (Supplementary data, Figure S5B -D) and the formation of the trisaccharide product (Supplementary data, Figure S5F ).
Taken together, these results demonstrate that monosaccharides are indeed transferred from the covalent GTA E303C → GalNAc species to disaccharide acceptors, producing trisaccharide products. Moreover, this result suggests that the covalent GTA E303C → GalNAc and GTB E303C → Gal species are catalytically competent and could represent intermediates in the enzymatic reactions. The slow product formation is not surprising given the lack of UDP, which is believed to be necessary for deprotonation of the acceptor. Moreover, in the absence of a donor or UDP, the enzyme is unable to make critical contacts with the acceptor and undergoes the conformational changes required in a normal catalytic cycle (Alfaro et al. 2008; Pesnot et al. 2010) . Thus, while the timescales for product formation are lower than those of a normal catalytic cycle, and while therefore the relevance to normal catalysis might be questioned, they are not unexpected given the complexity of GT reactions.
To confirm that the glycosyl-enzyme intermediates were in fact covalent in nature, solutions of GT E303C and their respective donor were acidified (to pH 3) with the addition of 0.5% formic acid following 4 h of incubation. Notably, ions corresponding to free monomeric GT E303C , as well as the monomeric form of the glycosyl-enzyme intermediate, were detected by ES-MS ( Figure 2D and Supplementary data, Figure S3D ). The absence of dimeric GT E303C ions and the broad charge-state distribution observed for the monomeric GT E303C ions are consistent with the acid denaturation of the enzymes. These findings confirm that both GTA E303C and GTB E303C are indeed glycosylated in the presence of the respective donor.
To identify the site of glycosylation in GTA E303C → GalNAc and GTB E303C → Gal, the intermediates, along with the nonglycosylated mutants, were digested in solution with trypsin. The resulting glycopeptides were separated from the tryptic peptides by reversed-phase liquid chromatography and analyzed by tandem MS (MS/MS) performed using collisioninduced dissociation (CID). Figure 3A shows the deconvoluted CID mass spectrum measured for the triply protonated glycopeptide 283 ACHQAMMVDQANGIEAVWHD CSHLNK 308 (where Cys 303 is underlined) obtained from the GTA E303C → GalNAc intermediate. The mass spectrum reveals an extensive series of y-ions resulting from the fragmentation of the glycosylated peptide, as well as the deglycosylated peptide, wherein cleavage of the glycosidic bond accompanies peptide bond cleavage ( Figure 3B and Supplementary data, Table S2 ). Notably, the smallest y-ion identified by MS/MS for the glycosylated peptide is y 6 , while for the non-glycosylated peptides, y 2 -y 5 ions were also detected. Furthermore, MS/MS analysis of the glycopeptide following treatment with iodoacetamide revealed that carbamidomethylation occurred at Cys 284 but not Cys 303 (Supplementary data, Figure S6 ), indicating that only Table S2 ).
Conclusions
In summary, this study demonstrates that direct ES-MS measurements, combined with trypsin digestion followed by MS/MS analysis of the fragments, provide a straightforward and effective strategy for identifying and characterizing covalent enzyme intermediates. Using this approach, direct evidence for the formation of covalent glycosyl-enzyme intermediates in the enzymatic reactions of mutants of GTA and GTB, GTA E303C and GTB E303C , was obtained. Furthermore, the sites of glycosylation for the two enzymes were conclusively identified. The existence of covalent intermediates raises the possibility that these mutant retaining GTs operate by a double-displacement enzymatic mechanism. As shown here, GTA and GTB, as well as other GT6 family enzymes, have a carboxylate properly oriented to act as a catalytic nucleophile. Other retaining GTs may lack such a residue or have Gln or Asn at an equivalent position (Lairson et al. 2008) . In these cases, either conformational changes occur to correctly position a catalytic nucleophile relative to substrates for a doubledisplacement mechanism or, possibly, alternate mechanisms, e.g. the S N i-like mechanism, are operational.
Experimental

Chemicals and reagents
The donor substrates UDP-GalNAc (1), UDP-Gal (2), iodoacetamide and ammonium bicarbonate were purchased from Sigma-Aldrich (Oakville, Canada). Ammonium acetate was purchased from Caledon Laboratory Chemicals (Georgetown, Canada). Dithiothreitol (DTT), urea, formic acid, high performance liquid chromatography (HPLC) grade water, HPLC grade methanol (MeOH) and HPLC grade acetonitrile (ACN) were purchased from Fisher Scientific (Ottawa, Canada). Sequencing grade modified trypsin was purchased from Promega (Madison, WI). The H-disaccharide acceptor (α-L-Fucp-(1 → 2)-β-D-Galp-O-(CH 2 ) 7 CH 3 ) used in this study was donated by Dr. Ole Hindsgaul (Carlsberg Laboratory).
Generation of mutants
Site-directed mutagenesis was carried out by the two-fragment method as previously described (Marcus et al. 2003 ) using wild-type GTA and GTB (aa 63-354) plasmid DNA as a template in the plasmid vector pCWΔlac. The primers used for mutagenesis, with codon substitutions in bold, were as follows: forward primer, 5′-TGG CAC GAC TGC TCC CAC CTG AAC AAA TAC CTG-3′; reverse primer, 5′-CAG GTG GGA GCA GTC GTG CCA AAC AGC TTC GAT AC-3′. Escherichia coli BL21 Gold Cells were used for expression.
Enzyme preparation and characterization
Recombinant soluble fragments of GTA E303C and GTB E303C mutants (MW 34, 494 and 34, 457 Da, respectively) composed of the catalytic domain as well as a part of the stem region were over-expressed in E. coli BL21 cells and purified using the same procedures as described previously for wild-type GTs (Marcus et al. 2003) . Kinetic studies were also performed as described (Marcus et al. 2003) . The enzymatic synthesis of trisaccharide products by the GT E303C mutants and the characterization of products were carried out using procedures described previously (Marcus et al. 2003) . To facilitate ES-MS analysis, the enzyme solutions were exchanged into a 50 mM ammonium acetate ( pH 7) using an Amicon ultracentrifugation filter (Millipore, Billerica, MA) with a molecular weight cut-off (MWCO) of 10 kDa. Protein concentrations were determined by lyophilizing an aliquot of the stock solution and weighing the mass of the corresponding protein pellet. Dialyzed GTA E303C and GTB E303C were stored −80°C until used.
To trap the covalent GTA E303C → GalNAc intermediate, GTA E303C (80 μM) was incubated with 1 (100 μM) in the presence of excess Mn 2+ (10 mM) in 50 mM 3-(N-morpholino)propanesulfonic acid (MOPS) buffer ( pH 7) at 37°C for 2 h to produce GTA E303C covalently bound to GalNAc (i.e. GTA E303C → GalNAc). The extent of conversion of GTA E303C to GTA E303C → GalNAc was confirmed by ES-MS. Before ES-MS analysis, the solutions were exchanged three times with 50 mM ammonium acetate ( pH 7) in the presence of 5 mM ethylenediaminetetraacetic acid, to remove excess Mn 2+ , and then five times with 50 mM ammonium acetate ( pH 7) using Amicon Ultra-0.5 centrifugal filter (Millipore) with MWCO of 10 kDa. The dialyzed solution was acidified using 10% acetic acid to adjust the pH to 3.3 prior to ES-MS analysis.
Once GTA E303C was fully converted to GTA E303C → GalNAc, the solution was dialyzed with 50 mM MOPS buffer ( pH 7) using Amicon Ultra-0.5 centrifugal filter with MWCO of 10 kDa to remove unreacted 1 and UDP (3). The H-antigen acceptor (20 mM) was added to the GTA E303C → GalNAc solution, and the mixture was incubated at 37°C for varying lengths of time prior to ES-MS analysis.
The formation of A-trisaccharide was confirmed in a separate experiment. GTA E303C (180 μM) was incubated with 1 (200 μM) in the presence of excess Mn 2+ (10 mM) in 50 mM MOPS buffer ( pH 7) at 37°C for 2.5 h. Following the conversion of GTA E303C to GTA E303C → GalNAc, the solution was dialyzed with 50 mM MOPS buffer ( pH 7) using Amicon Ultra-0.5 centrifugal filter with MWCO of 10 kDa to remove unreacted 1 and 3. The H-antigen acceptor (500 μM) was added to the purified GTA E303C → GalNAc solution, and the mixture was incubated at 37°C for 48 h. The A-trisaccharide
2 ) 7 CH 3 ) was isolated using C18 Zip-tips (Millipore). The reversed-phase bed was washed five times with 10 μL of 75% MeOH, equilibrated 10 times with 10 μL of water prior to applying the reaction mixture. The bed was washed 10 times with 10 μL of water, prior to eluting the bound trisaccharide with 10 μL of MeOH. MeOH was removed by evaporation using a vacuum centrifuge, and the dried product was stored in −20°C until used. The dried product was dissolved in 5 mM ammonium acetate ( pH 7) before ES-MS analysis.
In-solution protein digestion Glycosylated GT E303C mutants were digested using trypsin with or without alkylation (carbamidomethylation) of cysteine residues. For alkylation, GT E303C mutants were dissolved in 100 μL of 6 M urea, 100 mM Tris-HCl buffer (pH 8), reduced with 10 mM DTT for 1 h at room temperature and alkylated with 50 mM iodoacetate for 1 h in the dark at room temperature. The reaction mixture was dialyzed against 100 mM NH 4 HCO 3 buffer (pH 8) using an Amicon ultracentrifugation filter (Millipore) with a 5 kDa MWCO to remove excess reagents and was subsequently dried in a vacuum centrifuge.
The GT E303C samples were dissolved in 100 mM NH 4 HCO 3 buffer ( pH 8) (the GT E303C final concentration was between 1 and 10 μM) and digested for 4 h at 37°C using modified trypsin at 1:50 enzyme-to-protein molar ratio. The reaction was quenched by adding formic acid ( pH 3).
Fourier-transform ion cyclotron resonance mass spectrometry ES-MS measurements were performed using an Apex II 9.4 Tesla Fourier-transform ion cyclotron resonance mass spectrometer (FT-ICR-MS) (Bruker, Billerica, MA). The ES solutions were prepared from aqueous stock solutions of proteins and substrates with known concentration. Unless otherwise indicated, aqueous ammonium acetate was added to the ES solution to yield a final buffer concentration of 10 mM. ES was performed using borosilicate tubing (1.0 mm o.d., 0.68 mm i.d.), pulled to 5 μm o.d. at one end using a P-2000 micropipette puller (Sutter Instruments, Novato, CA). The electric field required to spray the solution in positive ion mode was established by applying a voltage of 1000 V to a platinum wire inserted inside the glass tip. The solution flow rate was typically 20 nL/min. The droplets and gaseous ions produced by ES were introduced into the mass spectrometer through a stainless steel capillary (i.d. 0.43 mm) maintained at an external temperature of 66°C. The ions sampled by the capillary (+50 V) was transmitted through a skimmer (−2 V) and stored electrodynamically in an r.f. hexapole for 4-8 s. Ions were ejected from the hexapole and accelerated to −2700 V into the superconducting magnet, decelerated and introduced into the ion cell. The trapping plates of the cell were maintained at 1.6 V throughout the experiment. The typical base pressure for the instrument was 5 × 10 −10 mbar. Data acquisition was controlled by an SGI R5000 computer running the Bruker Daltonics XMASS software, version 5.0. Mass spectra were obtained using standard experimental sequences with chirp broadband excitation. The time domain signal, consisting of the sum of 50-100 transients containing 128 K data points per transient, were subjected to one zero-fill prior to Fourier transformation.
Ultra-performance liquid chromatography tandem mass spectrometry The tryptic digests were analyzed using a hybrid quadrupole orthogonal acceleration time-of-flight mass spectrometer, Q-TOF Premier (Waters, Milford, MA), equipped with nanoACQUITY Ultra-performance liquid chromatography (UPLC) system (Waters). Briefly, 2 μL of the peptide solution was injected into a microprecolumn C 18 cartridge that was connected to an Atlantis dC18 column, 75 μm × 150 mm, 3 μm particle size (Waters). Solvent A consisted of 0.1% formic acid in water, and solvent B consisted of 0.1% formic acid in ACN. Tryptic peptides were separated using a 90 min gradient (1-5% solvent B for 5 min, 5-95% solvent B for 60 min, 95-2% solvent B for 25 min) and electrosprayed into the mass spectrometer at a flow rate of 350 nL/min. Real-time mass correction in MS and MS/MS modes was carried out using NanoLockSpray™ (Waters). Argon gas was used for Covalent intermediates of retaining glycosyltransferases the CID experiments. The data analysis was carried out using MassLynx version 4.1 (Waters).
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